chr16-3729307-C-T

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_004380.3(CREBBP):​c.5740G>A​(p.Val1914Met) variant causes a missense change. The variant allele was found at a frequency of 0.00000968 in 1,548,812 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1914L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000079 ( 0 hom. )

Consequence

CREBBP
NM_004380.3 missense

Scores

7
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 3.74

Publications

0 publications found
Variant links:
Genes affected
CREBBP (HGNC:2348): (CREB binding protein) This gene is ubiquitously expressed and is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. The protein encoded by this gene has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain. Mutations in this gene cause Rubinstein-Taybi syndrome (RTS). Chromosomal translocations involving this gene have been associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]
CREBBP Gene-Disease associations (from GenCC):
  • Rubinstein-Taybi syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • Rubinstein-Taybi syndrome due to CREBBP mutations
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • Menke-Hennekam syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.22076604).
BP6
Variant 16-3729307-C-T is Benign according to our data. Variant chr16-3729307-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 587612.
BS2
High AC in GnomAdExome4 at 11 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004380.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CREBBP
NM_004380.3
MANE Select
c.5740G>Ap.Val1914Met
missense
Exon 31 of 31NP_004371.2
CREBBP
NM_001079846.1
c.5626G>Ap.Val1876Met
missense
Exon 30 of 30NP_001073315.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CREBBP
ENST00000262367.10
TSL:1 MANE Select
c.5740G>Ap.Val1914Met
missense
Exon 31 of 31ENSP00000262367.5
CREBBP
ENST00000382070.7
TSL:1
c.5626G>Ap.Val1876Met
missense
Exon 30 of 30ENSP00000371502.3

Frequencies

GnomAD3 genomes
AF:
0.0000266
AC:
4
AN:
150366
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000591
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000313
AC:
5
AN:
160000
AF XY:
0.0000347
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000391
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000814
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000300
Gnomad OTH exome
AF:
0.000219
GnomAD4 exome
AF:
0.00000787
AC:
11
AN:
1398446
Hom.:
0
Cov.:
35
AF XY:
0.0000101
AC XY:
7
AN XY:
691114
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32094
American (AMR)
AF:
0.0000274
AC:
1
AN:
36470
Ashkenazi Jewish (ASJ)
AF:
0.0000396
AC:
1
AN:
25240
East Asian (EAS)
AF:
0.0000274
AC:
1
AN:
36488
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81170
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38414
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5358
European-Non Finnish (NFE)
AF:
0.00000645
AC:
7
AN:
1084908
Other (OTH)
AF:
0.0000172
AC:
1
AN:
58304
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.439
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000266
AC:
4
AN:
150366
Hom.:
0
Cov.:
32
AF XY:
0.0000136
AC XY:
1
AN XY:
73304
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40634
American (AMR)
AF:
0.00
AC:
0
AN:
15130
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3458
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5124
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4758
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10326
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000591
AC:
4
AN:
67650
Other (OTH)
AF:
0.00
AC:
0
AN:
2068
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000960
Hom.:
0
Bravo
AF:
0.0000302
ExAC
AF:
0.00000849
AC:
1

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Rubinstein-Taybi syndrome (1)
-
1
-
Rubinstein-Taybi syndrome due to CREBBP mutations (1)
-
1
-
Rubinstein-Taybi syndrome due to CREBBP mutations;C5193034:Menke-Hennekam syndrome 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.071
T
BayesDel_noAF
Benign
-0.14
CADD
Uncertain
24
DANN
Benign
0.96
DEOGEN2
Uncertain
0.47
T
Eigen
Benign
0.15
Eigen_PC
Uncertain
0.27
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.94
D
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.22
T
MetaSVM
Benign
-0.50
T
MutationAssessor
Benign
1.8
L
PhyloP100
3.7
PrimateAI
Uncertain
0.70
T
PROVEAN
Benign
-1.1
N
REVEL
Uncertain
0.32
Sift
Benign
0.12
T
Sift4G
Benign
0.22
T
Polyphen
0.96
D
Vest4
0.31
MutPred
0.17
Loss of catalytic residue at V1914 (P = 0.0711)
MVP
0.82
MPC
1.3
ClinPred
0.084
T
GERP RS
5.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.12
gMVP
0.13
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs760771706; hg19: chr16-3779308; COSMIC: COSV105864111; API